Off-label Use of Medications and Litigation Risk
The US Food and Drug Administration (FDA) requires manufacturers to demonstrate safety and efficacy of a medication as a condition of approval for indications in the product’s package insert. Often, the initial approved indications for a drug are narrow, based on the projected utility of